STAT Plus: FDA names genes that may interact with specific drugs, offering clarity to genetic testing industry
The burgeoning industry built around telling patients how their genes may interact with specific drugs has lately been in turmoil, the result of confusion and uncertainty about what exactly regulators will allow these genetic test makers to report.
On Thursday, the Food and Drug Administration offered some new clarity into its expectations for such tests.
Continue to STAT Plus to read the full story…
